5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. Med Pharm Rep [Internet]. 2024 Sep. 23 [cited 2026 Nov. 14];97(4):488-506. Available from: https://medpharmareports.com/index.php/mpr/article/view/2777